Global Phelan-McDermid Syndrome (PMS) Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Phelan-McDermid Syndrome (PMS) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Phelan-McDermid Syndrome (PMS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Phelan-McDermid Syndrome (PMS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Phelan-McDermid Syndrome (PMS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Phelan-McDermid Syndrome (PMS) players cover Cellcentric, Celgen, EpiGentek, Oryzon Genomics SA, Astex Pharmaceutucals, Sonic Genetics, Mendelian, AMO Pharma and Neuren Pharmaceuticals Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Phelan-McDermid syndrome (PMS) is a rare genetic condition that causes developmental and speech delays, behavioral problems and a weakened or no ability to feel pain or sweat. Phelan-McDermid syndrome is a congenital condition (condition that is present at birth) that can affect people of all genders.
LPI (LP Information)' newest research report, the “Phelan-McDermid Syndrome (PMS) Industry Forecast” looks at past sales and reviews total world Phelan-McDermid Syndrome (PMS) sales in 2022, providing a comprehensive analysis by region and market sector of projected Phelan-McDermid Syndrome (PMS) sales for 2023 through 2029. With Phelan-McDermid Syndrome (PMS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phelan-McDermid Syndrome (PMS) industry.
This Insight Report provides a comprehensive analysis of the global Phelan-McDermid Syndrome (PMS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phelan-McDermid Syndrome (PMS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phelan-McDermid Syndrome (PMS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phelan-McDermid Syndrome (PMS) and breaks down the forecast by treatment type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phelan-McDermid Syndrome (PMS).
This report presents a comprehensive overview, market shares, and growth opportunities of Phelan-McDermid Syndrome (PMS) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by treatment type
The global Phelan-McDermid Syndrome (PMS) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Phelan-McDermid Syndrome (PMS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Phelan-McDermid Syndrome (PMS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Phelan-McDermid Syndrome (PMS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Phelan-McDermid Syndrome (PMS) players cover Cellcentric, Celgen, EpiGentek, Oryzon Genomics SA, Astex Pharmaceutucals, Sonic Genetics, Mendelian, AMO Pharma and Neuren Pharmaceuticals Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Phelan-McDermid syndrome (PMS) is a rare genetic condition that causes developmental and speech delays, behavioral problems and a weakened or no ability to feel pain or sweat. Phelan-McDermid syndrome is a congenital condition (condition that is present at birth) that can affect people of all genders.
LPI (LP Information)' newest research report, the “Phelan-McDermid Syndrome (PMS) Industry Forecast” looks at past sales and reviews total world Phelan-McDermid Syndrome (PMS) sales in 2022, providing a comprehensive analysis by region and market sector of projected Phelan-McDermid Syndrome (PMS) sales for 2023 through 2029. With Phelan-McDermid Syndrome (PMS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phelan-McDermid Syndrome (PMS) industry.
This Insight Report provides a comprehensive analysis of the global Phelan-McDermid Syndrome (PMS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phelan-McDermid Syndrome (PMS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phelan-McDermid Syndrome (PMS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phelan-McDermid Syndrome (PMS) and breaks down the forecast by treatment type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phelan-McDermid Syndrome (PMS).
This report presents a comprehensive overview, market shares, and growth opportunities of Phelan-McDermid Syndrome (PMS) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by treatment type
- Applied Behavior Analysis
- Occupational Therapy
- Physical Therapy
- Others
- Hospitals
- Specialty Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cellcentric
- Celgen
- EpiGentek
- Oryzon Genomics SA
- Astex Pharmaceutucals
- Sonic Genetics
- Mendelian
- AMO Pharma
- Neuren Pharmaceuticals Limited
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Phelan-McDermid Syndrome (PMS) Market Size 2018-2029
2.1.2 Phelan-McDermid Syndrome (PMS) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Phelan-McDermid Syndrome (PMS) Segment by Treatment Type
2.2.1 Applied Behavior Analysis
2.2.2 Occupational Therapy
2.2.3 Physical Therapy
2.2.4 Others
2.3 Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type
2.3.1 Phelan-McDermid Syndrome (PMS) Market Size CAGR by Treatment Type (2018 VS 2022 VS 2029)
2.3.2 Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
2.4 Phelan-McDermid Syndrome (PMS) Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Others
2.5 Phelan-McDermid Syndrome (PMS) Market Size by Application
2.5.1 Phelan-McDermid Syndrome (PMS) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
3 PHELAN-MCDERMID SYNDROME (PMS) MARKET SIZE BY PLAYER
3.1 Phelan-McDermid Syndrome (PMS) Market Size Market Share by Players
3.1.1 Global Phelan-McDermid Syndrome (PMS) Revenue by Players (2018-2023)
3.1.2 Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Players (2018-2023)
3.2 Global Phelan-McDermid Syndrome (PMS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHELAN-MCDERMID SYNDROME (PMS) BY REGIONS
4.1 Phelan-McDermid Syndrome (PMS) Market Size by Regions (2018-2023)
4.2 Americas Phelan-McDermid Syndrome (PMS) Market Size Growth (2018-2023)
4.3 APAC Phelan-McDermid Syndrome (PMS) Market Size Growth (2018-2023)
4.4 Europe Phelan-McDermid Syndrome (PMS) Market Size Growth (2018-2023)
4.5 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Phelan-McDermid Syndrome (PMS) Market Size by Country (2018-2023)
5.2 Americas Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023)
5.3 Americas Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phelan-McDermid Syndrome (PMS) Market Size by Region (2018-2023)
6.2 APAC Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023)
6.3 APAC Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Phelan-McDermid Syndrome (PMS) by Country (2018-2023)
7.2 Europe Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023)
7.3 Europe Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Phelan-McDermid Syndrome (PMS) by Region (2018-2023)
8.2 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023)
8.3 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHELAN-MCDERMID SYNDROME (PMS) MARKET FORECAST
10.1 Global Phelan-McDermid Syndrome (PMS) Forecast by Regions (2024-2029)
10.1.1 Global Phelan-McDermid Syndrome (PMS) Forecast by Regions (2024-2029)
10.1.2 Americas Phelan-McDermid Syndrome (PMS) Forecast
10.1.3 APAC Phelan-McDermid Syndrome (PMS) Forecast
10.1.4 Europe Phelan-McDermid Syndrome (PMS) Forecast
10.1.5 Middle East & Africa Phelan-McDermid Syndrome (PMS) Forecast
10.2 Americas Phelan-McDermid Syndrome (PMS) Forecast by Country (2024-2029)
10.2.1 United States Phelan-McDermid Syndrome (PMS) Market Forecast
10.2.2 Canada Phelan-McDermid Syndrome (PMS) Market Forecast
10.2.3 Mexico Phelan-McDermid Syndrome (PMS) Market Forecast
10.2.4 Brazil Phelan-McDermid Syndrome (PMS) Market Forecast
10.3 APAC Phelan-McDermid Syndrome (PMS) Forecast by Region (2024-2029)
10.3.1 China Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.2 Japan Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.3 Korea Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.4 Southeast Asia Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.5 India Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.6 Australia Phelan-McDermid Syndrome (PMS) Market Forecast
10.4 Europe Phelan-McDermid Syndrome (PMS) Forecast by Country (2024-2029)
10.4.1 Germany Phelan-McDermid Syndrome (PMS) Market Forecast
10.4.2 France Phelan-McDermid Syndrome (PMS) Market Forecast
10.4.3 UK Phelan-McDermid Syndrome (PMS) Market Forecast
10.4.4 Italy Phelan-McDermid Syndrome (PMS) Market Forecast
10.4.5 Russia Phelan-McDermid Syndrome (PMS) Market Forecast
10.5 Middle East & Africa Phelan-McDermid Syndrome (PMS) Forecast by Region (2024-2029)
10.5.1 Egypt Phelan-McDermid Syndrome (PMS) Market Forecast
10.5.2 South Africa Phelan-McDermid Syndrome (PMS) Market Forecast
10.5.3 Israel Phelan-McDermid Syndrome (PMS) Market Forecast
10.5.4 Turkey Phelan-McDermid Syndrome (PMS) Market Forecast
10.5.5 GCC Countries Phelan-McDermid Syndrome (PMS) Market Forecast
10.6 Global Phelan-McDermid Syndrome (PMS) Forecast by Treatment Type (2024-2029)
10.7 Global Phelan-McDermid Syndrome (PMS) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Cellcentric
11.1.1 Cellcentric Company Information
11.1.2 Cellcentric Phelan-McDermid Syndrome (PMS) Product Offered
11.1.3 Cellcentric Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Cellcentric Main Business Overview
11.1.5 Cellcentric Latest Developments
11.2 Celgen
11.2.1 Celgen Company Information
11.2.2 Celgen Phelan-McDermid Syndrome (PMS) Product Offered
11.2.3 Celgen Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Celgen Main Business Overview
11.2.5 Celgen Latest Developments
11.3 EpiGentek
11.3.1 EpiGentek Company Information
11.3.2 EpiGentek Phelan-McDermid Syndrome (PMS) Product Offered
11.3.3 EpiGentek Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 EpiGentek Main Business Overview
11.3.5 EpiGentek Latest Developments
11.4 Oryzon Genomics SA
11.4.1 Oryzon Genomics SA Company Information
11.4.2 Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Product Offered
11.4.3 Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Oryzon Genomics SA Main Business Overview
11.4.5 Oryzon Genomics SA Latest Developments
11.5 Astex Pharmaceutucals
11.5.1 Astex Pharmaceutucals Company Information
11.5.2 Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Product Offered
11.5.3 Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Astex Pharmaceutucals Main Business Overview
11.5.5 Astex Pharmaceutucals Latest Developments
11.6 Sonic Genetics
11.6.1 Sonic Genetics Company Information
11.6.2 Sonic Genetics Phelan-McDermid Syndrome (PMS) Product Offered
11.6.3 Sonic Genetics Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sonic Genetics Main Business Overview
11.6.5 Sonic Genetics Latest Developments
11.7 Mendelian
11.7.1 Mendelian Company Information
11.7.2 Mendelian Phelan-McDermid Syndrome (PMS) Product Offered
11.7.3 Mendelian Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Mendelian Main Business Overview
11.7.5 Mendelian Latest Developments
11.8 AMO Pharma
11.8.1 AMO Pharma Company Information
11.8.2 AMO Pharma Phelan-McDermid Syndrome (PMS) Product Offered
11.8.3 AMO Pharma Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 AMO Pharma Main Business Overview
11.8.5 AMO Pharma Latest Developments
11.9 Neuren Pharmaceuticals Limited
11.9.1 Neuren Pharmaceuticals Limited Company Information
11.9.2 Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Product Offered
11.9.3 Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Neuren Pharmaceuticals Limited Main Business Overview
11.9.5 Neuren Pharmaceuticals Limited Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Phelan-McDermid Syndrome (PMS) Market Size 2018-2029
2.1.2 Phelan-McDermid Syndrome (PMS) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Phelan-McDermid Syndrome (PMS) Segment by Treatment Type
2.2.1 Applied Behavior Analysis
2.2.2 Occupational Therapy
2.2.3 Physical Therapy
2.2.4 Others
2.3 Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type
2.3.1 Phelan-McDermid Syndrome (PMS) Market Size CAGR by Treatment Type (2018 VS 2022 VS 2029)
2.3.2 Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
2.4 Phelan-McDermid Syndrome (PMS) Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Others
2.5 Phelan-McDermid Syndrome (PMS) Market Size by Application
2.5.1 Phelan-McDermid Syndrome (PMS) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
3 PHELAN-MCDERMID SYNDROME (PMS) MARKET SIZE BY PLAYER
3.1 Phelan-McDermid Syndrome (PMS) Market Size Market Share by Players
3.1.1 Global Phelan-McDermid Syndrome (PMS) Revenue by Players (2018-2023)
3.1.2 Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Players (2018-2023)
3.2 Global Phelan-McDermid Syndrome (PMS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHELAN-MCDERMID SYNDROME (PMS) BY REGIONS
4.1 Phelan-McDermid Syndrome (PMS) Market Size by Regions (2018-2023)
4.2 Americas Phelan-McDermid Syndrome (PMS) Market Size Growth (2018-2023)
4.3 APAC Phelan-McDermid Syndrome (PMS) Market Size Growth (2018-2023)
4.4 Europe Phelan-McDermid Syndrome (PMS) Market Size Growth (2018-2023)
4.5 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Phelan-McDermid Syndrome (PMS) Market Size by Country (2018-2023)
5.2 Americas Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023)
5.3 Americas Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phelan-McDermid Syndrome (PMS) Market Size by Region (2018-2023)
6.2 APAC Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023)
6.3 APAC Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Phelan-McDermid Syndrome (PMS) by Country (2018-2023)
7.2 Europe Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023)
7.3 Europe Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Phelan-McDermid Syndrome (PMS) by Region (2018-2023)
8.2 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023)
8.3 Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHELAN-MCDERMID SYNDROME (PMS) MARKET FORECAST
10.1 Global Phelan-McDermid Syndrome (PMS) Forecast by Regions (2024-2029)
10.1.1 Global Phelan-McDermid Syndrome (PMS) Forecast by Regions (2024-2029)
10.1.2 Americas Phelan-McDermid Syndrome (PMS) Forecast
10.1.3 APAC Phelan-McDermid Syndrome (PMS) Forecast
10.1.4 Europe Phelan-McDermid Syndrome (PMS) Forecast
10.1.5 Middle East & Africa Phelan-McDermid Syndrome (PMS) Forecast
10.2 Americas Phelan-McDermid Syndrome (PMS) Forecast by Country (2024-2029)
10.2.1 United States Phelan-McDermid Syndrome (PMS) Market Forecast
10.2.2 Canada Phelan-McDermid Syndrome (PMS) Market Forecast
10.2.3 Mexico Phelan-McDermid Syndrome (PMS) Market Forecast
10.2.4 Brazil Phelan-McDermid Syndrome (PMS) Market Forecast
10.3 APAC Phelan-McDermid Syndrome (PMS) Forecast by Region (2024-2029)
10.3.1 China Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.2 Japan Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.3 Korea Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.4 Southeast Asia Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.5 India Phelan-McDermid Syndrome (PMS) Market Forecast
10.3.6 Australia Phelan-McDermid Syndrome (PMS) Market Forecast
10.4 Europe Phelan-McDermid Syndrome (PMS) Forecast by Country (2024-2029)
10.4.1 Germany Phelan-McDermid Syndrome (PMS) Market Forecast
10.4.2 France Phelan-McDermid Syndrome (PMS) Market Forecast
10.4.3 UK Phelan-McDermid Syndrome (PMS) Market Forecast
10.4.4 Italy Phelan-McDermid Syndrome (PMS) Market Forecast
10.4.5 Russia Phelan-McDermid Syndrome (PMS) Market Forecast
10.5 Middle East & Africa Phelan-McDermid Syndrome (PMS) Forecast by Region (2024-2029)
10.5.1 Egypt Phelan-McDermid Syndrome (PMS) Market Forecast
10.5.2 South Africa Phelan-McDermid Syndrome (PMS) Market Forecast
10.5.3 Israel Phelan-McDermid Syndrome (PMS) Market Forecast
10.5.4 Turkey Phelan-McDermid Syndrome (PMS) Market Forecast
10.5.5 GCC Countries Phelan-McDermid Syndrome (PMS) Market Forecast
10.6 Global Phelan-McDermid Syndrome (PMS) Forecast by Treatment Type (2024-2029)
10.7 Global Phelan-McDermid Syndrome (PMS) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Cellcentric
11.1.1 Cellcentric Company Information
11.1.2 Cellcentric Phelan-McDermid Syndrome (PMS) Product Offered
11.1.3 Cellcentric Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Cellcentric Main Business Overview
11.1.5 Cellcentric Latest Developments
11.2 Celgen
11.2.1 Celgen Company Information
11.2.2 Celgen Phelan-McDermid Syndrome (PMS) Product Offered
11.2.3 Celgen Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Celgen Main Business Overview
11.2.5 Celgen Latest Developments
11.3 EpiGentek
11.3.1 EpiGentek Company Information
11.3.2 EpiGentek Phelan-McDermid Syndrome (PMS) Product Offered
11.3.3 EpiGentek Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 EpiGentek Main Business Overview
11.3.5 EpiGentek Latest Developments
11.4 Oryzon Genomics SA
11.4.1 Oryzon Genomics SA Company Information
11.4.2 Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Product Offered
11.4.3 Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Oryzon Genomics SA Main Business Overview
11.4.5 Oryzon Genomics SA Latest Developments
11.5 Astex Pharmaceutucals
11.5.1 Astex Pharmaceutucals Company Information
11.5.2 Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Product Offered
11.5.3 Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Astex Pharmaceutucals Main Business Overview
11.5.5 Astex Pharmaceutucals Latest Developments
11.6 Sonic Genetics
11.6.1 Sonic Genetics Company Information
11.6.2 Sonic Genetics Phelan-McDermid Syndrome (PMS) Product Offered
11.6.3 Sonic Genetics Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sonic Genetics Main Business Overview
11.6.5 Sonic Genetics Latest Developments
11.7 Mendelian
11.7.1 Mendelian Company Information
11.7.2 Mendelian Phelan-McDermid Syndrome (PMS) Product Offered
11.7.3 Mendelian Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Mendelian Main Business Overview
11.7.5 Mendelian Latest Developments
11.8 AMO Pharma
11.8.1 AMO Pharma Company Information
11.8.2 AMO Pharma Phelan-McDermid Syndrome (PMS) Product Offered
11.8.3 AMO Pharma Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 AMO Pharma Main Business Overview
11.8.5 AMO Pharma Latest Developments
11.9 Neuren Pharmaceuticals Limited
11.9.1 Neuren Pharmaceuticals Limited Company Information
11.9.2 Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Product Offered
11.9.3 Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Neuren Pharmaceuticals Limited Main Business Overview
11.9.5 Neuren Pharmaceuticals Limited Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Phelan-McDermid Syndrome (PMS) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Applied Behavior Analysis
Table 3. Major Players of Occupational Therapy
Table 4. Major Players of Physical Therapy
Table 5. Major Players of Others
Table 6. Phelan-McDermid Syndrome (PMS) Market Size CAGR by Treatment Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 8. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 9. Phelan-McDermid Syndrome (PMS) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 12. Global Phelan-McDermid Syndrome (PMS) Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Player (2018-2023)
Table 14. Phelan-McDermid Syndrome (PMS) Key Players Head office and Products Offered
Table 15. Phelan-McDermid Syndrome (PMS) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Phelan-McDermid Syndrome (PMS) Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Regions (2018-2023)
Table 20. Global Phelan-McDermid Syndrome (PMS) Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Phelan-McDermid Syndrome (PMS) Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Phelan-McDermid Syndrome (PMS) Market Size Market Share by Country (2018-2023)
Table 24. Americas Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 25. Americas Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 26. Americas Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 28. APAC Phelan-McDermid Syndrome (PMS) Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Region (2018-2023)
Table 30. APAC Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 31. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 32. APAC Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 34. Europe Phelan-McDermid Syndrome (PMS) Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Country (2018-2023)
Table 36. Europe Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 37. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 38. Europe Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 44. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Phelan-McDermid Syndrome (PMS)
Table 47. Key Market Challenges & Risks of Phelan-McDermid Syndrome (PMS)
Table 48. Key Industry Trends of Phelan-McDermid Syndrome (PMS)
Table 49. Global Phelan-McDermid Syndrome (PMS) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Phelan-McDermid Syndrome (PMS) Market Size Forecast by Treatment Type (2024-2029) & ($ Millions)
Table 52. Global Phelan-McDermid Syndrome (PMS) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Cellcentric Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 54. Cellcentric Phelan-McDermid Syndrome (PMS) Product Offered
Table 55. Cellcentric Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Cellcentric Main Business
Table 57. Cellcentric Latest Developments
Table 58. Celgen Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 59. Celgen Phelan-McDermid Syndrome (PMS) Product Offered
Table 60. Celgen Main Business
Table 61. Celgen Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Celgen Latest Developments
Table 63. EpiGentek Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 64. EpiGentek Phelan-McDermid Syndrome (PMS) Product Offered
Table 65. EpiGentek Main Business
Table 66. EpiGentek Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. EpiGentek Latest Developments
Table 68. Oryzon Genomics SA Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 69. Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Product Offered
Table 70. Oryzon Genomics SA Main Business
Table 71. Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Oryzon Genomics SA Latest Developments
Table 73. Astex Pharmaceutucals Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 74. Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Product Offered
Table 75. Astex Pharmaceutucals Main Business
Table 76. Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Astex Pharmaceutucals Latest Developments
Table 78. Sonic Genetics Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 79. Sonic Genetics Phelan-McDermid Syndrome (PMS) Product Offered
Table 80. Sonic Genetics Main Business
Table 81. Sonic Genetics Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Sonic Genetics Latest Developments
Table 83. Mendelian Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 84. Mendelian Phelan-McDermid Syndrome (PMS) Product Offered
Table 85. Mendelian Main Business
Table 86. Mendelian Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Mendelian Latest Developments
Table 88. AMO Pharma Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 89. AMO Pharma Phelan-McDermid Syndrome (PMS) Product Offered
Table 90. AMO Pharma Main Business
Table 91. AMO Pharma Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. AMO Pharma Latest Developments
Table 93. Neuren Pharmaceuticals Limited Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 94. Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Product Offered
Table 95. Neuren Pharmaceuticals Limited Main Business
Table 96. Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Neuren Pharmaceuticals Limited Latest Developments
Table 1. Phelan-McDermid Syndrome (PMS) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Applied Behavior Analysis
Table 3. Major Players of Occupational Therapy
Table 4. Major Players of Physical Therapy
Table 5. Major Players of Others
Table 6. Phelan-McDermid Syndrome (PMS) Market Size CAGR by Treatment Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 8. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 9. Phelan-McDermid Syndrome (PMS) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 12. Global Phelan-McDermid Syndrome (PMS) Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Player (2018-2023)
Table 14. Phelan-McDermid Syndrome (PMS) Key Players Head office and Products Offered
Table 15. Phelan-McDermid Syndrome (PMS) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Phelan-McDermid Syndrome (PMS) Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Regions (2018-2023)
Table 20. Global Phelan-McDermid Syndrome (PMS) Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Phelan-McDermid Syndrome (PMS) Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Phelan-McDermid Syndrome (PMS) Market Size Market Share by Country (2018-2023)
Table 24. Americas Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 25. Americas Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 26. Americas Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 28. APAC Phelan-McDermid Syndrome (PMS) Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Region (2018-2023)
Table 30. APAC Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 31. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 32. APAC Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 34. Europe Phelan-McDermid Syndrome (PMS) Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Country (2018-2023)
Table 36. Europe Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 37. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 38. Europe Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Treatment Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Table 44. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Phelan-McDermid Syndrome (PMS)
Table 47. Key Market Challenges & Risks of Phelan-McDermid Syndrome (PMS)
Table 48. Key Industry Trends of Phelan-McDermid Syndrome (PMS)
Table 49. Global Phelan-McDermid Syndrome (PMS) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Phelan-McDermid Syndrome (PMS) Market Size Forecast by Treatment Type (2024-2029) & ($ Millions)
Table 52. Global Phelan-McDermid Syndrome (PMS) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Cellcentric Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 54. Cellcentric Phelan-McDermid Syndrome (PMS) Product Offered
Table 55. Cellcentric Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Cellcentric Main Business
Table 57. Cellcentric Latest Developments
Table 58. Celgen Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 59. Celgen Phelan-McDermid Syndrome (PMS) Product Offered
Table 60. Celgen Main Business
Table 61. Celgen Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Celgen Latest Developments
Table 63. EpiGentek Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 64. EpiGentek Phelan-McDermid Syndrome (PMS) Product Offered
Table 65. EpiGentek Main Business
Table 66. EpiGentek Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. EpiGentek Latest Developments
Table 68. Oryzon Genomics SA Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 69. Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Product Offered
Table 70. Oryzon Genomics SA Main Business
Table 71. Oryzon Genomics SA Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Oryzon Genomics SA Latest Developments
Table 73. Astex Pharmaceutucals Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 74. Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Product Offered
Table 75. Astex Pharmaceutucals Main Business
Table 76. Astex Pharmaceutucals Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Astex Pharmaceutucals Latest Developments
Table 78. Sonic Genetics Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 79. Sonic Genetics Phelan-McDermid Syndrome (PMS) Product Offered
Table 80. Sonic Genetics Main Business
Table 81. Sonic Genetics Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Sonic Genetics Latest Developments
Table 83. Mendelian Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 84. Mendelian Phelan-McDermid Syndrome (PMS) Product Offered
Table 85. Mendelian Main Business
Table 86. Mendelian Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Mendelian Latest Developments
Table 88. AMO Pharma Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 89. AMO Pharma Phelan-McDermid Syndrome (PMS) Product Offered
Table 90. AMO Pharma Main Business
Table 91. AMO Pharma Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. AMO Pharma Latest Developments
Table 93. Neuren Pharmaceuticals Limited Details, Company Type, Phelan-McDermid Syndrome (PMS) Area Served and Its Competitors
Table 94. Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Product Offered
Table 95. Neuren Pharmaceuticals Limited Main Business
Table 96. Neuren Pharmaceuticals Limited Phelan-McDermid Syndrome (PMS) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Neuren Pharmaceuticals Limited Latest Developments
LIST OF FIGURES
Figure 1. Phelan-McDermid Syndrome (PMS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Phelan-McDermid Syndrome (PMS) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Phelan-McDermid Syndrome (PMS) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Phelan-McDermid Syndrome (PMS) Sales Market Share by Country/Region (2022)
Figure 8. Phelan-McDermid Syndrome (PMS) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type in 2022
Figure 10. Phelan-McDermid Syndrome (PMS) in Hospitals
Figure 11. Global Phelan-McDermid Syndrome (PMS) Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Phelan-McDermid Syndrome (PMS) in Specialty Clinics
Figure 13. Global Phelan-McDermid Syndrome (PMS) Market: Specialty Clinics (2018-2023) & ($ Millions)
Figure 14. Phelan-McDermid Syndrome (PMS) in Others
Figure 15. Global Phelan-McDermid Syndrome (PMS) Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application in 2022
Figure 17. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Player in 2022
Figure 18. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Phelan-McDermid Syndrome (PMS) Market Size 2018-2023 ($ Millions)
Figure 20. APAC Phelan-McDermid Syndrome (PMS) Market Size 2018-2023 ($ Millions)
Figure 21. Europe Phelan-McDermid Syndrome (PMS) Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size 2018-2023 ($ Millions)
Figure 23. Americas Phelan-McDermid Syndrome (PMS) Value Market Share by Country in 2022
Figure 24. United States Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Region in 2022
Figure 29. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type in 2022
Figure 30. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application in 2022
Figure 31. China Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Country in 2022
Figure 38. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Figure 39. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Figure 40. Germany Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Figure 47. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 54. APAC Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 55. Europe Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 57. United States Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 58. Canada Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 61. China Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 62. Japan Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 63. Korea Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 65. India Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 66. Australia Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 67. Germany Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 68. France Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 69. UK Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 70. Italy Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 71. Russia Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 72. Spain Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 75. Israel Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 78. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share Forecast by Treatment Type (2024-2029)
Figure 79. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Phelan-McDermid Syndrome (PMS) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Phelan-McDermid Syndrome (PMS) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Phelan-McDermid Syndrome (PMS) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Phelan-McDermid Syndrome (PMS) Sales Market Share by Country/Region (2022)
Figure 8. Phelan-McDermid Syndrome (PMS) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type in 2022
Figure 10. Phelan-McDermid Syndrome (PMS) in Hospitals
Figure 11. Global Phelan-McDermid Syndrome (PMS) Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Phelan-McDermid Syndrome (PMS) in Specialty Clinics
Figure 13. Global Phelan-McDermid Syndrome (PMS) Market: Specialty Clinics (2018-2023) & ($ Millions)
Figure 14. Phelan-McDermid Syndrome (PMS) in Others
Figure 15. Global Phelan-McDermid Syndrome (PMS) Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application in 2022
Figure 17. Global Phelan-McDermid Syndrome (PMS) Revenue Market Share by Player in 2022
Figure 18. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Phelan-McDermid Syndrome (PMS) Market Size 2018-2023 ($ Millions)
Figure 20. APAC Phelan-McDermid Syndrome (PMS) Market Size 2018-2023 ($ Millions)
Figure 21. Europe Phelan-McDermid Syndrome (PMS) Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size 2018-2023 ($ Millions)
Figure 23. Americas Phelan-McDermid Syndrome (PMS) Value Market Share by Country in 2022
Figure 24. United States Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Region in 2022
Figure 29. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type in 2022
Figure 30. APAC Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application in 2022
Figure 31. China Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Country in 2022
Figure 38. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Figure 39. Europe Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Figure 40. Germany Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Treatment Type (2018-2023)
Figure 47. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Phelan-McDermid Syndrome (PMS) Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 54. APAC Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 55. Europe Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 57. United States Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 58. Canada Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 61. China Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 62. Japan Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 63. Korea Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 65. India Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 66. Australia Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 67. Germany Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 68. France Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 69. UK Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 70. Italy Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 71. Russia Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 72. Spain Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 75. Israel Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Phelan-McDermid Syndrome (PMS) Market Size 2024-2029 ($ Millions)
Figure 78. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share Forecast by Treatment Type (2024-2029)
Figure 79. Global Phelan-McDermid Syndrome (PMS) Market Size Market Share Forecast by Application (2024-2029)
